Blood Safety and Quality Regulations

Similar documents
Official Journal of the European Union

Lessons for Transfusion Laboratory Staff. from the 2007 SHOT Report SHOT SERIOUS HAZARDS OF TRANSFUSION

NHS Blood and Transplant (NHSBT) Board 30 November Clinical Governance Report 01 August 30 th September 2017

List of Policies and Standard Operational Procedures (SOPs) for cell collection, processing and transplantation programmes

Joint Statement on the Application of Good Clinical Practice to Training for Researchers

Guidance for registered pharmacies preparing unlicensed medicines

Clinical. Medication Errors and Medicine Defect Reporting SOP. Document Control Summary. Contents

Blood / Blood Products Transfusion A Liquid Transplant

ZAMBIA MEDICINES REGULATORY AUTHORITY EMPLOYMENT OPPORTUNITY

Title Controlled Storage of Blood and Blood Products Standard Operating Procedure

POL:02:UP:001:07:NIBT PAGE 1 of 6 ISSUE DATE: 12 DECEMBER 2014 EFFECTIVE DATE: 9 JANUARY 2015

Apheresis Medicine Physician Training Around the World:

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Quality Management Training for Blood Transfusion Services

The Royal Society for the Promotion of Health. Level 3 Award in Supervising Food Safety in Catering

EHR] A INSPECTION REPORT. Guy s Hospital Pharmacy St Thomas Street London SE1 9RT. Safeguarding public health

Guidance for MRC units on HTA licence applications for storage of human samples for research purposes

POL:08:LP:003:03:NIBT PAGE : 1 of 5. Document Title: NIBTS POLICY FOR RETURN AND RE-ISSUE OF BLOOD AND BLOOD COMPONENTS

ST. JAMES S HOSPITAL BLOOD TRANSFUISON DEPARTMENT

The Update June 2016

Right blood, right patient, right time. RCN guidance for improving transfusion practice. Past review date Use with caution

The Royal Society for Public Health

POL:00:QP:001:03:NIBT PAGE 1 of 8. Document Details Document Number: POL:00:QP:001:03:NIBT No. of Appendices: 1 Supersedes Number: 00:02:QP:001:NIBT

The Royal Society for Public Health

European network of paediatric research (EnprEMA)

SOP:07:QA:070:08:NIBT PAGE 1 of 26

Qualifications Support Pack 03. Making Claims & Results

SOUTH EASTERN TRUST. Point of Care Testing (POCT) Policy Ellie Duly, Chair POCT Committee. Approval date: Operational Date: November 2014

Irradiated blood products - Pathway for requesting To provide healthcare professionals with clear guidance on the use of irradiated blood products.

REPORT OF BLOOD SAFETY REVIEW

Blood Bank Rotations Goals and Objectives. Rotation Director: Robertson Davenport, M.D.

Trust Policy for Blood Transfusion

Blood Transfusion Policy. Version Number: 6.1 Controlled Document Sponsor: Controlled Document Lead: On: December 2014.

2010 No HEALTH CARE AND ASSOCIATED PROFESSIONS. The Medical Profession (Responsible Officers) Regulations 2010

7 th Edition FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration

Northern Ireland Social Care Council. NISCC (Registration) Rules 2017

Need for transfusion? Supply, safety, PBM and consent Katy Cowan - PBM Practitioner

Level 3 Award in Food Safety for Food Manufacturing

GUIDANCE FOR PROVIDERS ON THE APPOINTMENT OF A REGISTERED MANAGER

OFFICE OF SOCIAL SERVICES TRAINING SUPPORT PROGRAMME FOR THE VOLUNTARY AND COMMUNITY SECTOR

RESERVOIR LEGISLATION IN NORTHERN IRELAND

SALE, SUPPLY AND ADMINISTRATION OF MEDICINES BY ALLIED HEALTH PROFESSIONALS UNDER PATIENT GROUP DIRECTIONS

PROCEDURE FOR BLOOD COMPONENTS/PRODUCTS PRE- ADMINISTRATION CHECKS AND TRACEABILITY

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC

FACT (Foundation for the Accreditation of Cellular Therapy): Elizabeth Perry, MD

Patient Blood Management Certification Revisions

Medical Device Alert. Action

Job Description. Haematology Laboratory Temple Street Children s University Hospital Temple Street Dublin 1.

Clinical Standards ~ September Blood Transfusion

Unannounced Care Inspection Report 30 June Medcom Personnel Ltd

Therapeutic Apheresis Services Service Portfolio

Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research

The Nursing and Midwifery Order 2001 (SI 2002/253)

CLINICAL FELLOWSHIP PROGRAM IN TRANSFUSION MEDICINE

Procedures for the initial education and training of pharmacists and pharmacy technicians in Great Britain and Northern Ireland

Registration of a new pharmacy premises

Post : Cleaner. St. Mary s Primary School, Draperstown. Candidate Information Pack

Quality Medical and Laboratory Practice in Cellular Therapy

Human Samples in Research

Food Hygiene Rating Scheme A Report for the National Assembly of Wales

CELLULAR THERAPY PRODUCT COLLECTION, PROCESSING, AND ADMINISTRATION DOCUMENT SUBMISSION REQUIREMENTS

Renewal Inspection Report. Ninewells Hospital Date of Inspection: 13 May 2009 Date of Licence Committee: 12 August 2009

RECIPIENT NOTIFICATION OF A BLOOD COMPONENT OR BLOOD PRODUCT RECALL NLBCP-048. Issuing Authority

CARE OF THE DYING IN THE NHS. The Buckinghamshire Communique 11 th March The Nuffield Trust

Standard Operating Procedure (SOP) Research and Development Office

MINIMUM CRITERIA FOR REACH AND CLP INSPECTIONS 1

RECOMMENDATIONS ON CLOUD OUTSOURCING EBA/REC/2017/03 28/03/2018. Recommendations. on outsourcing to cloud service providers

Competency Assessment for Non Medical Prescribing of Blood and Blood Components

COMMUNITY LIAISON COMMITTEE, BC & YUKON

RECRUITMENT AND VETTING CHECKS POLICY

Transfusion Medicine Residency Training Program

Pre-inspection documentation

Announced Care Inspection of Rosconnor Clinic. 17 February 2016

abcdefghijklmnopqrstu

Temporary Registration Guidelines

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

Post-accreditation monitoring report: Association of Business Executives (ABE) March 2008 QCA/08/3699

abcdefghijklmnopqrstu

ACCOUNT NO. MED. REC. NO. NAME BIRTHDATE. Patient Identification ALL ORDERS MUST BE MARKED IN INK WITH A CHECKMARK ( ) TO BE ACTIVE.

Guide to registration for providers of social work services

Registration prescribed information handbook

Application for Recognition or Expansion of Recognition

Administration of blood components. Denise Watson Patient Blood Management Practitioner 11th January, 2016

HAEMOVIGILANCE POLICY

Recommendations on outsourcing to cloud service providers (EBA/REC/2017/03)

Guidance for Applicants

Guilds. City. Level 2 Diploma in Health and Social Care (Adults) for Wales and Northern Ireland ( ) Candidate logbook 501/1260/0

HAEMOVIGILANCE. Ms. Emma O Riordan Haemovigilance, CNM2 (Acting) Ms. Bríd Doyle, MSc. FAMLS. Haemovigilance Co-ordinator, (Acting)

HYWEL DDA LOCAL HEALTH BOARD. Transfusion Policy. Completed Action: Addresses all aspects of transfusion with blood and blood components

Electronic Blood Tracking System

Level 3 Award in Supervising Food Safety in Catering

POLICY FOR THE TRANSFUSION OF BLOOD AND BLOOD COMPONENTS

POCKET GUIDE TO THE ACCREDITATION STANDARDS (ISO 15189:2014)

Cosmetic procedures: what do I need to consider?

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

Post Market Surveillance Requirements. SAMED Regulatory Conference 2 December 2015

Good decision making: Investigations and threshold criteria guidance

DESCRIPTION/OVERVIEW This document standardizes the transfusion of packed red blood cells and/or other blood components.

DISCLOSURE & BARRING SERVICE POLICY AND PROCEDURES

Overseas Pharmacists Assessment Programme (OSPAP)

Transcription:

Safeguarding public health Blood Safety and Quality Regulations Thursday 29 September 2005 Hastings Stormont Hotel, Belfast

Safeguarding public health Applying for a Blood Establishment Authorisation: Who, What, When, Where September/October 2005

WHO A Blood Establishment Authorisation is needed for the following: Whole blood collection Autologous whole blood collection Testing donor samples Apheresis collection of components Applying for a Blood Establishment Authorisation September/October 2005

Processing Whole Blood into: Red cells Platelets Granulocytes Fresh frozen plasma Recovered plasma (for discard) Cryoprecipitate Cryoprecipitate depleted plasma Buffy coat Applying for a Blood Establishment Authorisation September/October 2005

Components processed into: Methylene blue treated plasma Irradiated components Washed components Splitting into paediatric (small volume) packs Pooling cryoprecipitate Manipulation of haematocrit Applying for a Blood Establishment Authorisation September/October 2005

Statistics 629 letters sent out to blood authorities, transplant centres and hospitals (health service and private) 553 have replied To date the YES responses are 13 9 hospitals and the four National Blood Authorities Hospital Region Letters Sent Responses England 295 276 Wales 17 17 Scotland 82 63 Northern Ireland 12 11 Private 175 141 Transplant Centres 48 45 Applying for a Blood Establishment Authorisation September/October 2005

WHAT Application for a Blood Establishment Authorisation 3 sections: Section 1: Background information, any other licences held Section 2: Applicant details Section 3: Site information including multiple sites for one applicant Activity Processes Personnel Responsible Person (Blood) Hospitals and Blood Banks supplied (UK & overseas) Facilities on site Signed declaration Application form and guidance notes on its completion are available on the MHRA web site www.mhra.gov.uk Applying for a Blood Establishment Authorisation September/October 2005

Responsible Person (Blood) At least one person must be nominated - can be multiple nominations. The application must include a CV for each nominated person and each person must sign that section containing their details. The Responsible Person has very specific tasks including the quality assurance processes, labelling and traceability and disclosure of information. Applying for a Blood Establishment Authorisation September/October 2005

Qualifications The SI is very specific regarding qualifications that person must have: a diploma, certificate or other evidence of formal qualification in the field of medical or biological sciences awarded on completion of a university study course OR a course recognised as an equivalent course by the Secretary of State* and practical post-graduate experience in areas of work relevant to the responsibilities of the responsible person under these Regulations for at least 2 years, in an establishment (or more than one establishment) authorised in any member state to undertake activities related to the collection or testing or both of blood and components or to their preparation, storage and distribution. Applying for a Blood Establishment Authorisation September/October 2005

WHEN DEADLINE - 8th November 2005 Assessment of Application: Review the application Review the suitability of the Responsible Person (Blood) Trigger inspection Inspector assesses suitability of premises and quality management system Blood Establishment Authorisation issued when inspector confirms suitability Any establishments not authorised by 8th November 2005 must cease those processes covered by this Statutory Instrument. Applying for a Blood Establishment Authorisation September/October 2005

Contacts Medicines and Healthcare products Regulatory Agency 17th Floor Market Towers 1 Nine Elms Lane London SW8 5NQ Contacts: Julian Hubble - 020 7084 2585 julian.hubble@mhra.gsi.gov.uk Judith Thomas - 020 7084 2905 judith.thomas@mhra.gsi.gov.uk Fax: 020 7084 2595 Applying for a Blood Establishment Authorisation September/October 2005

Safeguarding public health Blood Safety and Quality Regulations Thursday 29 September 2005 Hastings Stormont Hotel, Belfast

Safeguarding public health Compliance Reports Barbara Morris

Definition of Hospital Blood Bank Article 3(f) of Directive 2002/98/EC Citation, commencement and interpretation of SI 2005/50 any unit within a hospital which stores and distributes, and may perform compatibility tests on blood and blood components exclusively for use within hospital facilities, including hospital based transfusion activities.

Dilemma Directive 2002/98/EC exempts hospital blood banks from routine inspection. Competent authority required to ensure hospital blood banks comply with requirements for personnel, quality system, storage, transport, distribution, traceability, reporting serious adverse events and reactions etc.

Requirements for Hospital Blood Banks Regulation 10 of SI 2005/50- Annual Report Systems in place to ensure compliance with regulations Report any changes which may affect compliance

Hospital Blood Bank Compliance Report Completed reports due to MHRA by 31/12/2005 Assessment of reports to be completed by MHRA by the end of March 2006 Blood banks which do not appear to be in compliance will be inspected by the MHRA

Hospital Blood Bank Compliance Report Information required Status of CPA accreditation Details of personnel recruitment and training Details of Quality Management System

Quality Management System Quality Incident Reports Self inspection Technical Agreements Complaints

Quality Management System Component Recall Receipt and storage of components Distribution of components Traceability Adverse reactions and Events

MHRA Expectations Quality Incident Reports Reporting incidents Investigation to root cause Corrective action Preventing recurrence Tracking/Trending

MHRA Expectations Personnel Suitably qualified Documented work instructions Trained to work instructions for tasks performed Records of training

MHRA Expectations Distribution Satellite units supplied Transport conditions Responsibility for satellite unit Maintenance of equipment

MHRA Expectations Traceability/Component Recall Final disposition of ALL components Linkage between donation number and recipient Records of final disposition Written procedure for Recall of components

MHRA Expectations Self Inspection Regular review of all activities Process for correcting deficiencies

Compliance Report See example form in handout Note - not a final version

MHRA Process Report submitted to licensing Referred to inspectors and reviewed No Further information Acceptable? Yes Response Acceptable? No Inspection Yes Letter of compliance sent to blood bank

Safeguarding public health Blood Safety and Quality Regulations Thursday 29 September 2005 Hastings Stormont Hotel, Belfast

Safeguarding public health Inspection of Blood Banks and Blood Establishments Barbara Morris

Reasons for Inspection Blood Establishments Routine inspection once every two years Additional inspections if considered necessary Response to Serious Adverse Event or Serious Adverse Reaction Hospital Blood Banks Application for Blood Establishment Authorisation (BEA) Response to Serious Adverse Event or Serious Adverse Reaction Compliance report follow-up

When is a blood bank not a blood bank?? Collection of whole blood or apheresis components for transfusion. Secondary processing of components - Irradiation of blood components - Pooling/splitting components - Washing blood components

Overview of Inspection Process Inspection arranged Inspection conducted Follow-up completed BEA

Inspection Process Preparation Opening Meeting Departmental visits, staff interviews, document review Closing Meeting Issue of post inspection letter, containing list of deficiencies Review of responses Closure of inspection, report issued

Preparation Site Update site information Review documents Review processes Inspector Site Information Review BEA application or Compliance Report Previous report Haemovigilance reports

Opening Meeting Opening Meeting by the Inspector - Introduction of inspection team - Information gathering - Tentative schedule Opportunity for establishment to present an overview of activities Opportunity to ask questions

The Actual Inspection Obtaining Information Witnessing Tasks being performed Reviewing Documented Procedures Asking Questions - Who? What? When? Where? Investigating Issues - Why?

Inspection process System Inspection based upon: Quality management Personnel Premises and Equipment Documentation Blood Processing Complaints/component recall Self Inspection

Inspection: Quality System QUALITY SYSTEM Documented procedures Training records Change control Self inspection/ supplier audits Component recall/customer complaints Technical agreements

Closing Meeting Closing meeting by inspector Presentation of findings Opportunity for establishment to provide further information Acceptance of findings Notification of next steps

Review of responses Responses from the establishment received by the inspector 28 days after delivery of the post inspection letter. Corrective action taken/to be taken reviewed Further information requested if required to provide satisfactory correction of the deficiency Close-out letter sent when inspector assured that the deficiencies have been adequately addressed

Common deficiencies Blood Establishments Equipment - validation, calibration, verification Quality System - incident reporting, technical agreements self inspection Documentation - records incomplete, corrections, illegible Personnel - training, training records

Common deficiencies Hospital Blood Banks Quality System - lack of documented system for quality incidents - lack of written procedures for required processes (self inspection, component recall etc) Equipment - maintenance, calibration, validation

For Further Information www.mhra.gov.uk For information on SABRE please email: sabre@mhra.gsi.gov.uk For electronic copies of presentations please email: conferences@mhra.gsi.gov.uk

Safeguarding public health Blood Safety and Quality Regulations Thursday 29 September 2005 Hastings Stormont Hotel, Belfast